In the treatment of obsessive-compulsive disorder, tau is used to treat the obsessive-compulsive disorder.

• 1. 龙齿在制备用于治疗强迫症的药物中的应用 [P] . 中国专利： CN107929320A . 2018-04-20
• 2. 用于治疗强迫症的组合物、装置和方法 [P] . 中国专利： CN110290790A . 2019-09-27
• 3. The eradication of B cells is like enanti CD20 antibody or theta P alpha A, a alpha tau alpha as an annual treatment. These devices are obsessive-compulsive disorder. [P] . CY1118918T1 . 2018-01-10

  机译： 消灭B细胞就像是enanti CD20抗体或theta P alpha A（每年一次使用alpha tau alpha）。这些装置是强迫症。

• 4. The use of alpha gamma, Magenis, and Smith to treat drugs is an obsessive-compulsive disorder. [P] . CY1111430T1 . 2015-08-05

  机译： 使用阿尔法伽玛，马盖尼斯和史密斯来治疗药物是一种强迫症。

• 5. The way of the delta form is to treat the obsessive-compulsive disorder. [P] . CY1107452T1 . 2012-12-19

  机译： 三角洲形式的方法是治疗强迫症。

• 1. Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder [J] . Andrea Amerio, Anna Odone 综合精神医学（英文） . 2018,第006期
• 2. Serum Levels of Brain-Derived Neurotrophic Factor in Patients with Obsessive-Compulsive Disorder in a Japanese Population [J] . Takeyuki Akimoto, Chihiro Sutoh, Masaru Kuno, 精神病学期刊（英文） . 2021,第001期
• 3. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder. [J] . Shavitt RG, Valerio C, Fossaluza V, European archives of psychiatry and clinical neuroscience . 2010,第2期
• 4. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder. [J] . Uguz F General hospital psychiatry . 2010,第5期
• 5. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder. [J] . Sasayama D, Sugiyama N, Imai J, Psychiatry and clinical neurosciences . 2009,第2期
• 6. Altered Intramodular Functional Connectivity in Drug Naïve Obsessive-Compulsive Disorder Patients [C] . Qianqian Ye, Zongfeng Zhang, Qing Fan, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2020
• 7. A cognitive dissonance approach to understanding and treating obsessive-compulsive disorder. [D] . Wright, Edward C. 2010
• 8. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention [O] . Gunvor Launes, Kristen Hagen, Lars-Göran Öst, 2020
• 9. Morphologic and functional connectivity alterations of corticostriatal and default mode network in treatment-naïve patients with obsessive-compulsive disorder. [O] . Jingming Hou, Lingheng Song, Wei Zhang, 2013

• 1. Obsessive-compulsive disorder:Evidence-based treatments and future directions for research [J] . Caleb W Lack . 世界精神病学杂志 . 2012,第6期
• 2. Comorbid bipolar disorder and obsessive-compulsive disorder:state of the art in pediatric paitents [J] . Matteo TONNA ,Andrea AMERIO ,Anna ODONE . 上海精神医学 . 2015,第006期
• 3. Antiglutamatergic agents for obsessive-compulsive disorder:Where are we now and what are possible future prospects? [J] . Annalisa Maraone ,Lorenzo Tarsitani ,Irene Pinucci . 世界精神病学杂志 . 2021,第9期
• 4. 心理治疗联合药物治疗强迫症个案浅析 [C] . 史梅芳 . 2013浙江省医学会行为医学分会第一届学术年会 . 2013
• 5. 强迫症药物合并认知行为疗法与单用药物治疗的随机对照研究及强迫症与SLC1A1基因多态性的关联研究 [A] . 任建娟 . 2012